Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SPCEO1on Nov 14, 2022 10:22am
173 Views
Post# 35096436

RE:Another crappy week

RE:Another crappy week Let's be fair about this - there is no evidence to suggest either the company will announce something about cancer this week or the opposite. Your emotions are speaking rather than your brain. The possibility exists that we could hear something from TH at any time but we have no insight into that at all.  So, yes, that is a bit maddening but it is just the normal situation for a biotech. 

But I think you are right when you say the markets are pure stupidity right now. But again, that has been true for many, many years. It comes with the territory. If you invest, prepare for a lot of whacky behavior as most of us let our emotions do the talking rather than our brains!

Biobob wrote: Another week of nothing by the look of it again this morning.  These markets are just pure stupidity atm.. I get it like my friend Joe would say... but geez it's beyond embarassement trying to explain the situation to incredulous shareholders... 


<< Previous
Bullboard Posts
Next >>